Medical Loophole Enables Recreational‑Strength Cannabis

In Britain, private online clinics legally prescribe ultra‑high‑THC, lifestyle‑branded cannabis flowers imported from North America under a 'medicinal' label. This bypasses the original intent of tightly controlled medical access and blurs the line with recreational use, while psychosis concerns mount. — It shows how medicalization can become a backdoor to commercialization, forcing regulators to confront public‑health risks and tighten governance of 'medical' cannabis markets.